EUVIMEDOdkrijte EUVIMED
Open access · CC BY-NC 4.0

Protocolized screening and detection of occult alcohol use before and after liver transplant: Lessons learned from a quality improvement initiative

N Lim iD, T M Leventhal iD, M J Thomson iD, M Hassan, J Thompson, A Adams iD, S Chinnakotla iD, V Humphreville iD, R Kandaswamy iD, V Kirchner iD, T L Pruett iD, L Schuller and 2 more

Clinical Transplantation · 2023-05-23

DOI: 10.1111/ctr.15036 ↗

At a glance

Journal article in Clinical Transplantation, published online on 2023-05-23. Written by N Lim and 13 co-authors. Institution: Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA. Major MEDLINE topics: Liver Transplantation, Liver Diseases, Alcoholic, Alcoholism. Cited 9 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

INTRODUCTION: Detection of alcohol (ETOH) use with biomarkers provides an opportunity to intervene and treat patients with alcohol use disorder before and after liver transplant (LT). We describe our center's experience using urine ethyl glucuronide (EtG) and serum phosphatidylethanol (PEth) in alcohol screening protocols. METHODS: Single-center, retrospective review of patients presenting for LT evaluation, patients waitlisted for LT for alcohol-associated liver disease (ALD), and patients who received a LT for ALD over a 12-month period, from October 1, 2019 through September 30, 2020. Patients were followed from waitlisting to LT, or for up to 12 months post-LT. We monitored protocol adherence to screening for ETOH use- defined as completion of all possible tests over the follow-up period- at the initial LT visit, while on the LT waitlist and after LT. RESULTS: During the study period, 227 patients were evaluated for LT (median age 57 years, 58% male, 78% white, 54.2% ALD). Thirty-one patients with ALD were placed on the waitlist, and 38 patients underwent LT for ALD during this time period. Protocolized adherence to screening for alcohol use was higher for PEth for all LT evaluation patients (191 [84.1%] vs. 146 [67%] eligible patients, p < .001), in patients with ALD waitlisted for LT (22 [71%] vs. 14 (48%] eligible patients, p = .04) and after LT for ALD, 20 (33 [86.8%] vs. 20 [52.6%] eligible patients, p < .01). Few patients with a positive test in any group completed chemical dependency treatment. CONCLUSIONS: When screening for ETOH use in pre- and post-LT patients, protocol adherence is higher using PEth compared to EtG. While protocolized biomarker screening can detect recurrent ETOH use in this population, engagement of patients into chemical dependency treatment remains challenging.

Subjects

MeSH terms (MEDLINE)

Liver TransplantationLiver Diseases, AlcoholicAlcoholismHumansMaleMiddle AgedFemaleQuality ImprovementAlcohol DrinkingEthanolBiomarkersGlucuronates

Author keywords

alcoholethyl glucuronideliver transplantphosphatidylethanolscreening

Substances

EthanolBiomarkersethyl glucuronideGlucuronates

Authors and institutions

  • Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, Minnesota, USA.
  • Division of Transplant Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
  • Division of Abdominal Transplantation, Stanford University, Palo Alto, California, USA.
  • University of Minnesota Physicians, Minneapolis, Minnesota, USA.
  • Complex Care Analytics, Fairview Health Services, Minneapolis, Minnesota, USA.

ORCID profiles: N Lim, T M Leventhal, M J Thomson, A Adams, S Chinnakotla, V Humphreville, R Kandaswamy, V Kirchner, T L Pruett, J Lake

Cite

APA

Lim, N., Leventhal, T. M., Thomson, M. J., Hassan, M., Thompson, J., Adams, A., Chinnakotla, S., Humphreville, V., Kandaswamy, R., Kirchner, V., Pruett, T. L., Schuller, L., McCarty, M., & Lake, J. (2023). Protocolized screening and detection of occult alcohol use before and after liver transplant: Lessons learned from a quality improvement initiative. Clinical Transplantation. https://doi.org/10.1111/ctr.15036

Vancouver

Lim N, Leventhal TM, Thomson MJ, Hassan M, Thompson J, Adams A, et al. Protocolized screening and detection of occult alcohol use before and after liver transplant: Lessons learned from a quality improvement initiative. Clinical Transplantation. 2023. doi:10.1111/ctr.15036

BibTeX
@article{Lim2023,
  author = {Lim, N and Leventhal, T M and Thomson, M J and Hassan, M and Thompson, J and Adams, A and Chinnakotla, S and Humphreville, V and Kandaswamy, R and Kirchner, V and Pruett, T L and Schuller, L and McCarty, M and Lake, J},
  title = {Protocolized screening and detection of occult alcohol use before and after liver transplant: Lessons learned from a quality improvement initiative},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.15036}
}
Start for free →